The transit of dosage forms through the colon

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 17-25

  Wilson, Clive G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Colon; Colon transit measurements; Colonic motility; Controlled release dosage forms

Indexed keywords

CODEINE; EDETATE CHROMIUM CR 51; EUDRAGIT; GEFITINIB; LACTULOSE; PENTETATE INDIUM IN 111; POLACRILIN; QUININE; TECHNETIUM 99M; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM;

COLON; COLON MOTILITY; CONTROLLED RELEASE FORMULATION; DOSIMETRY; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG TRANSPORT; GAMMA SCINTIGRAPHY; HUMAN; PRIORITY JOURNAL; REVIEW; ANATOMY AND HISTOLOGY; DELAYED RELEASE FORMULATION; DRINKING; DRUG ADMINISTRATION; DRUG DOSAGE FORM; EATING; FEEDING BEHAVIOR; GASTROINTESTINAL TRANSIT; MEDICINAL CHEMISTRY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHYSIOLOGY; SCINTISCANNING; TIME;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; COLON; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRINKING; DRUG ADMINISTRATION SCHEDULE; EATING; FEEDING BEHAVIOR; GASTROINTESTINAL TRANSIT; HUMANS; PARTICLE SIZE; TIME FACTORS;

EID: 77954316197     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.044     Document Type: Review

References (62)

1. Abrahamsson B., Alpsten M., Johnsson U.E., Lunberg P.J., Sandberg A., Sundgren M., Svenheden A., Tolli J. Gastro-intestinal transit of a multiple-unit formulation (metoprolol CR/ZOK) and a non-disintegrating tablet with the emphasis on colon. Int. J. Pharm. 1996, 140:229-235.
2. Adkin D.A., Davis S.S., Sparrow R.A., Wilding I.R. Colonic transit of different sized tablets in healthy-subjects. J. Control. Release 1993, 23:147-156.
3. Alvarez W.C., Freedlander B.L. The rate of progress of food residues through the bowel. J. Am. Med. Assoc. 1924, 83:576-580.
4. AMS Task Force Measurement of gastrointestinal transit. Dig. Dis. Sci. 2005, 50:989-1004.
5. Barrow L., Spiller R.C., Wilson C.G. Pathological influences on colonic motility: implications for drug delivery. Adv. Drug Deliv. Rev. 1981, 7:201-218.
6. Barrow L., Steed K.P., Spiller R.C., Maskell N.A., Brown K., Watts P.J., Melia C.D., Davies M.C., Wilson C.G. Quantitative, non-invasive assessment of antidiarrhoeal actions of codeine using an experimental model of diarrhoea in man. Dig. Dis. Sci. 1993, 38:996-1003.
7. 67Ga-citrate in healthy subjects and those with chronic idiopathic constipation. J. Nucl. Med. 1999, 40:277-282.
8. Basile M., Neri M., Carriero A., Casciardi S., Comani S., Del Gratta C., Di Donato L., Di Luzio S., Macri M.A., Pasquarelli A. Measurement of segmental transit through the gut in man. A novel approach by the biomagnetic method. Dig. Dis. Sci. 1992, 37:1537-1543.
9. Cherbut C. Motor effects of short chain fatty acids in the gastrointestinal tract. Proc. Nutr. Soc. 2003, 62:95-99.
10. Clarke G.M., Newton J.M., Short M.D. Gastrointestinal transit of pellets of differing size and density. Int. J. Pharm. 1993, 100:81-92.
11. Coupe A.J., Davis S.S., Evans D.F., Wilding I.R. The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms. Int. J. Pharm. 1992, 78:69-76.
12. Coupe A.J., Davis S.S., Evans D.F., Wilding I.R. Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage forms. J. Control. Release 1992, 20:155-162.
13. Cremonini F., Mullan B.P., Camilleri M., Burton D.D., Rank M.R. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment. Pharmacol. Ther. 2002, 16:1781-1790.
14. Cuche G., Cuber J.C., Malbert C.H. Ileal short chain fatty acid inhibit gastric motility by a humoral pathway. Am. J. Physiol. 2000, 279:G925-G930.
15. Devereux J.E., Newton J.M., Short M.B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol. 1990, 42:500-501.
16. Diakidou A., Vertzoni M., Goumas K., Abrahamsson B., Söderlind E., Dressman J.B., Reppas C. Characterisation of the contents of the ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm. Res. 2009, 26:2141-2151.
17. Goodman K., Hodges L.A., Band J., Stevens H.N.E., Weitschies W., Wilson C.G. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. Eur. J. Pharm. Biopharm. 2010, 74:84-92.
18. Graff J., Brinch K., Madsen J.L. Simplified scintigraphic methods for measuring gastrointestinal transit times. Clin. Physiol. 2001, 2:251-259.
19. Haggar R., Kumar D., Benson M., Grundy A. Colonic motor activity in slow-transit idiopathic constipation as identified by 24-h pancolonic ambulatory manometry. Neurogastroenterol. Motil. 2003, 15:515-522.
20. Hardy J.G., Wilson C.G., Wilson E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 1985, 37:874-877.
21. Hebden J.M., Wilson C.G., Spiller R.C., Gilchrist P.J., Blackshaw E., Frier M.E., Perkins A.C. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm. Res. 1999, 16:1087-1092.
22. Hebden J.M., Gilchrist P.J., Perkins A.C., Wilson C.G., Spiller R.S. Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. Pharm. Res. 1999, 16:1254-1259.
23. Hebden J.M., Gilchrist P.J., Blackshaw E., Frier M.E., Perkins A.C., Wilson C.G., Spiller R.C. Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations. Eur. J. Gastroenterol. Hepatol. 1999, 11:1379-1385.
24. Hebden J.M., Blackshaw P.E., Perkins A.C., Wilson C.G., Spiller R.C. Limited exposure of left colon to daily dosed oral formulations in active distal ulcerative colitis: exploration of poor response to treatment?. Aliment. Pharmacol. Ther. 2000, 14:55-161.
25. Hinton J.M., Lennard-Jones J.E., Young A.C. A new method for studying gut transit times using radio-opaque markers. Gut 1969, 10:842-847.
26. Hodges L.A., Connolly S.A., Band J., O'Mahony B., Ugurlu T., Turkoglu M., Wilson C.G., Stevens H.N.E. Scintigraphic evaluation of colon targeting pectin-HPMC tablets in healthy volunteers. Int. J. Pharm. 2009, 370:144-150.
27. Holdstock D.J., Misiewicz J.J. Factors controlling colonic motility: colonic pressures and transit after meals in patients with total gastrectomy, pernicious anaemia or duodenal ulcer. Gut 1970, 11:100-110.
28. Krevsky B., Malmud L.S., D'Ercole F., Maurer A.H., Fisher R.S. Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans. Gastroenterology 1986, 91:1102-1112.
29. McDougall C.L., Wong R., Scudera P., Lesser M., DeCosse J.J. Colonic mucosal pH in humans. Dig. Dis. Sci. 1993, 38:542-545.
30. Media S., Christensen P., Lauge I., Al-Hashimi M., Laurberg S., Krogh K. Reproducibility and validity of radiographically determined gastrointestinal and segmental colonic transit times in spinal cord-injured patients. Spinal Cord 2009, 47:72-75.
31. Miller T.L., Wolin M.J. Methanogens in human and animal intestinal tracts. Syst. Appl. Microbiol. 1986, 7:223-229.
32. Misiewicz J.J. Colonic motility. Gut 1975, 16:311-314.
33. Notgi A., Hutchinson R., Kumar D., Smith N.B., Harding L.K. Simplified method for the measurement of segmental colonic transit time. Gut 1994, 35:976-981.
34. Ooi T., Shibata T., Sato R., Ohno H., Kinoshita S., Thuoc T.L., Taguchi S. An azoreductase, aerobic NADH-dependent flavoprotein discovered from Bacillus sp.: functional expression and enzymatic characterization. Appl. Microbiol. Biotechnol. 2007, 75:377-386.
35. Parker G., Wilson C.G., Hardy J.G. The effect of capsule size and density on transit through the proximal colon. J. Pharm. Pharmacol. 1988, 40:375-377.
36. Pimentel P., Lin H.C., Enayati P., van den Burg B., Lee H.-R., Chen J.H., Park S., Yuthana K.Y., Conklin J. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1089-G1095.
37. Podczeck F., Course N.C., Newton J.M. Determination of the gastric emptying of solid dosage forms using gamma-scintigraphy: a problem of image timing and mathematical analysis. Eur. J. Nucl. Med. 1999, 26:373-378.
38. Podczeck F., Course N.C., Newton J.M., Short M.B. The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers. J. Pharm. Pharmacol. 2007, 59:23-27.
39. Press A.G., Hauptmann I.A., Hauptmann L., Fuchs B., Fuchs M., Ewe K., Ramdori G. Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 1998, 12:673-678.
40. Price J.M.C., Davis S.S., Wilding I.R. Characterization of colonic transit of nondisintegrating tablets in healthy subjects. Dig. Dis. Sci. 1993, 38:1015-1021.
41. Proano M., Camilleri M., Phillips S.F., Brown M.L., Thomforde G.M. Transit of solids through the human colon - regional quantification in the unprepared bowel. Am. J. Physiol. 1990, 21:G856-G862.
42. Rambaud J.-C., Buts J.-P., Corthier G., Flourie B. Gut Microflora: Digestive Physiology and Pathology 2006, John Libbey Eurotext, Paris. J.-C. Rambaud (Ed.).
43. Rau J., Stoltz A. Oxygen-insensitive nitroreductases NfsA and NfsB of Escherichia coli function under anaerobic conditions as Lawsone-dependent azo reductases. Appl. Environ. Microbiol. 2003, 69:3448-3455.
44. Rausch T., Beglinger C., Alam N., Gyr K., Meier R. Effect of transdermal application of nicotine on colonic transit in healthy non-smoking volunteers. Neurogastroenterol. Motil. 1998, 10:263-270.
45. Read N.W., Al-Janabi M.N., Holgate A.M., Barber D.C., Edwards C.A. Simultaneous measurement of gastric emptying. Small bowel residence and colonic filling of a solid meal by the use of the gamma camera. Gut 1986, 27:300-308.
46. Roberts J.P., Newell M.S., Deeks J.J., Waldron D.W., Garvie N.W., Williams N.S. Oral [In-111]-DTPA scintigraphic assessment of colonic transit in constipated subjects. Dig. Dis. Sci. 1993, 38:1032-1039.
47. Sathyan G., Hwang S., Gupta S.K. Effect of dosing time on the total intestinal transit time of non-disintegrating systems. Int. J. Pharm. 2000, 204:47-51.
48. Schiller C., Fröhlich C.P., Giessmann T., Siegmund W., Mönnikes H., Hosten N., Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 2005, 22:971-979.
49. Scott A.M., Kellow J.E., Shuter B., Nolan J.M., Hoschl R., Jones M.P. Effects of cigarette smoking on solid and liquid intragastric distribution and gastric emptying. Gastroenterology 1993, 104:410-416.
50. Stathopoulos E., Schlageter V., Meyrat B. Magnetic pill tracking: a novel non-invasive tool for investigation of human digestive motility. Neurogastroenterol. Motil. 2005, 17:148-154.
51. Stirrup V., Ledingham S., Thomas M., Pye G., Evans D.F. Redox potential measurement in the gastrointestinal tract in man. Gut 1990, 31:A1171.
52. Stubbs J.B., Valenzuela G.A., Stubbs C.C., Croft B.Y., Teates C.D., Plankey M.W., McCallum R.W. A noninvasive scintigraphic assessment of the colonic transit of nondigestible solids in man. J. Nucl. Med. 1991, 32:1375-1381.
53. Sullivan S.K., Smith P.L. Bicarbonate secretion by the rabbit proximal colon. Am. J. Physiol. 1986, 251:G436-G445.
54. Takaya T., Ikeda C., Imagawa N., Niwa K., Takada K. Development of a colon delivery capsule and pharmacological activity of recombinant human granulocyte colony-stimulating factor in beagle dogs. J. Pharm. Pharmacol. 1995, 47:474-478.
55. Wagener S., Shankar K.R., Turnock R.R., Lamont G.L., Baillie C.T. Colonic transit time - what is normal?. J. Pediatr. Surg. 2004, 39:166-169.
56. Watts P.J., Barrow L., Steed K.P. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int. J. Pharm. 1992, 87:215-221.
57. Weitschies W., Kotitz R., Cordini D., Trahms L. High-resolution monitoring of the gastrointestinal transit of a magnetically marked capsule. J. Pharm. Sci. 1997, 86:1218-1222.
58. Weitschies W., Kosch O., Monnikes H., Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 2005, 57:1210-1222.
59. Wilson, C.G., 2008. Colonic drug delivery. In: Rathbone, M., Hadgraft, J., Roberts, M. (Eds.), Modified Release Drug Delivery Technology, 2nd ed. In: Swarbrick, J. (Ed.), Drugs and the Pharmaceutical Sciences Series, Marcel Dekker Inc., New York, pp. 307-314.
60. Wilson C.G., McJury M., O'Mahony B., Frier M., Perkins A.C. Imaging of oily formulations in the gastrointestinal tract. Adv. Drug Deliv. Rev. 1997, 25:91-101.
61. Wilson K., O'Mahony B., Lindsay B., Band J., Hodges L., Wilson C., Stevens H. Transit of magnetic tablets using magnetic moment imaging and gamma scintigraphy. Proc. Control. Release Soc. 2007, Abstract #186.
62. Wilson C.G., O'Mahony B., Connolly S.M., Cantarini M.V., Farmer M.R., Dickinson P.A., Smith R.P., Swaisland H.C. Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?. Int. J. Pharm. 2009, 376:7-12.